Trial intelligence / Profile preview

IOP Changes with Loteprednol vs Dexamethasone After Pterygium Surgery

NCT00781300Phase 4Completed

Sponsor
Federal University of São Paulo
Start
Mar 2006
Primary completion
Nov 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of loteprednol etabonate in pterygium (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Intraocular Pressure at 6 weeks. Started Mar 2006; status: completed.

02

Drugs

loteprednol etabonate
03

Conditions

pterygium

Beyond the preview

Go deeper on NCT00781300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00781300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call